What researchers published on Gaucher-kór
1565 papers, newest first.
Showing 160 of 1565
A Novel Glucocerebrosidase Allosteric Activator Prevents MPTP-Induced Neurodegeneration in Mice.International journal of molecular sciences
A New Selection Strategy to Enrich Dopaminergic Neurons Facilitates Comparisons Between Patient iPSC-Derived Lines.International journal of molecular sciences
Regional newborn screening for Gaucher disease in Kumamoto and Fukuoka Prefectures, Japan: an updated report and long-term outcomes of screen-identified patients.Molecular genetics and metabolism
How Can We Reliably Highlight Nanoscale Lipid Heterogeneities in Erythrocyte Membranes?Analytical chemistry
Beyond a Single Lysosomal Threshold: Interpreting Bistability in the GCase1-α-Synuclein Axis A Letter to the Editor on Reed et al., "Parkinson's disease, Gaucher disease, and bistability in the lysosomal degradation pathway".Mathematical biosciences
Pulmonary involvement in Gaucher disease patients receiving enzyme replacement therapy: a cross-sectional analysis of radiological and functional lung abnormalities.European journal of pediatrics
EsetismertetésChanges in bone density and metabolism marker levels in type I Gaucher's disease following annual zoledronic acid hydrate administration: A case report.Bone reports
Velaglucerase alfa for Gaucher disease in Japan: Long-term post-marketing surveillance data from a unique population with high rates of neuronopathic subtypes.Molecular genetics and metabolism reports
ÁttekintésLysosomal alkalinization: a convergent mechanism in lysosomal storage disorders and classical neurodegenerative diseases.Cell communication and signaling : CCS
Clinical History and Burden of Gaucher Disease Type 3: A Cross-Sectional Multinational Study.JIMD reports
EsetismertetésExtended Deletion in the GBA1 Gene, Masked by Apparent p.Asn409Ser Homozygous: Diagnostic Implications and the Need for an Integrated Genetic Approach.International journal of molecular sciences
A multiscale signaling-biophysical framework reveals mechanisms of macrophage-mediated RBC clearance in sickle cell and Gaucher disease.PNAS nexus
Lipidomic Profiling of Peripheral Extracellular Vesicles as a Potential Source of Biomarkers in Gaucher Disease.Cells
Insights into morbidity and mortality in Gaucher disease: a cohort study.Molecular genetics and metabolism reports
Quantifying the Biophysical Properties of Red Blood Cells in Gaucher Disease.Biophysical journal
ÁttekintésThyroid involvement in lysosomal storage diseases: current evidence and clinical perspectives.Reviews in endocrine & metabolic disorders
Diagnostic Delay in Gaucher Disease and the Role of Gastroenterology in the Diagnostic Journey: A Real-World Cohort Study.Journal of clinical medicine
Parkinson's disease, Gaucher disease, and bistability in the lysosomal degradation pathway.Mathematical biosciences
New insights into bone pathology through a transcriptomic profiling of an osteoblast model of Gaucher disease.Molecular genetics and metabolism reports
Applying a Pareto-Based Efficiency Frontier to Inform Value-Based Pricing for Gaucher Disease Therapies in Brazil.Pharmacoepidemiology and drug safety
EsetismertetésCase Report: From suspected congenital rubella to a lysosomal storage disorder-diagnostic challenges in a neonate with findings strongly suggestive of Gaucher disease.Frontiers in pediatrics
Rare Diseases as Engines of Biomedical Innovation: Lessons for Gene Therapy and Common Disease.The Yale journal of biology and medicine
Pathway-level transcriptional convergence between Gaucher disease and Common variable immunodeficiency reveals concordant interferon and antigen-processing signatures.Immunology letters
Integrating Gaucher disease (GD) into mainstream hematological curriculum training.HemaSphere
EsetismertetésThe close relationship between a rare disease and a common disease: Case report of a patient with gaucher disease and parkinsonism.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Generation and Characterization of an Osteoclastic Cell Model of Gaucher's Bone Disease.Calcified tissue international
ÁttekintésAmbroxol in Gaucher disease and GBA1-related Parkinson disease: an updated systematic review.Acta neurologica Belgica
ÁttekintésMiglustat in Neuronopathic Lysosomal Storage Disorders: Biological Rationale, Clinical Evidence, and Limits of Repurposing.International journal of molecular sciences
Megfigyeléses vizsgálatImpaired α-Granule Secretion Dominates Longitudinal Agonist-Induced Platelet Dysfunction in Gaucher Disease.International journal of molecular sciences
PreprintMA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.Research square
Clinical course and biomarkers in patients with type 1 Gaucher disease and Parkinson's disease: A retrospective cohort study.Molecular genetics and metabolism reports
Computational evaluation of EPA-PC binding to GCase in neuronopathic Gaucher disease.Current research in structural biology
EsetismertetésEarly-onset parkinsonism as a presenting feature of suspected type 1 Gaucher disease with two pathogenic GBA1 variants: a case report.Frontiers in neuroscience
Hemophagocytic Lymphohistiocytosis in a Patient With Gaucher Disease Having a Homozygous STXBP3 Variant.Pediatric blood & cancer
EsetismertetésDelayed Diagnosis of Type 1 Gaucher Disease at Age 15 After Years of Mild Cytopenias and Splenomegaly: A Case Report and Long-Term Follow-Up.The American journal of case reports
Clinical and genetic landscape of neuronopathic gaucher disease in Ukraine: hepatosplenomegaly and diagnostic delay.Orphanet journal of rare diseases
PreprintQuantifying the Biophysical Properties of Red Blood Cells in Gaucher Disease.ArXiv
ÁttekintésDisruptions in speech, language and social communication in lysosomal storage diseases.Neuroscience and biobehavioral reviews
Multiplex MSMS measurement of lysosomal enzymes enables incidental diagnosis of acid sphingomyelinase deficiency in patients evaluated for Gaucher disease.Molecular genetics and metabolism
Novel splice site variants in GBA1 are associated with Gaucher disease and genotype-phenotype correlations.Brain & development
Clinical Experience With Eliglustat in Children With Gaucher Disease Type 1.American journal of medical genetics. Part A
EsetismertetésRAF/MEK clamp inhibition with avutometinib and cetuximab in RAF1 S257L-mutated, anti-EGFR-refractory metastatic colorectal cancer in Gaucher's disease.The oncologist
Diagnostic Challenge of Pediatric Gaucher Disease in a Low-Resource South Asian Setting: A Case Report.Clinical case reports
Coexistence of Multiple Myeloma and Gaucher Disease: A Pilot Study.Turkish journal of haematology : official journal of Turkish Society of Haematology
The cutaneous phenotypic landscape of Gaucher disease type 1: A clinic-based cross-sectional study.Journal of the American Academy of Dermatology
Establishment of a human induced pluripotent stem cell line (PNUSCRi003-A) from a patient with Gaucher disease carrying compound heterozygous p.Arg87Trp and p.Arg296Gln variants in the GBA1 gene.Stem cell research
Crumpled cytoplasm, clear diagnosis: the iconic morphology of Gaucher disease.Blood
Esetismertetés[Paediatric Gaucher disease type 1: diagnostic challenges in presence of hepatosplenomegaly and pancytopenia].Annales de biologie clinique
ÁttekintésThe Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease.International journal of molecular sciences
Long-Term Outcomes of Enzyme Replacement Therapy in Indian Patients with Gaucher Disease - A Multicentric Study.Indian journal of pediatrics
A genome-wide screen identifies that PLCG2 restrains lysosomal GCase activity.Proceedings of the National Academy of Sciences of the United States of America
Clinical, biochemical and molecular spectrum of acute neuronopathic type 2 Gaucher disease from India.BMC pediatrics
Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies.eLife
True Gaucher's Disease or Pseudo-Gaucher Presentations.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
EsetismertetésGaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.Journal of inherited metabolic disease
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease.American journal of hematology
persistent pain and fatigue drive reduced quality of life in treated Gaucher disease type 1: a cross-sectional analysis.Orphanet journal of rare diseases
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.Molecular genetics and metabolism reports
Liver MR elastography in Gaucher disease: Longitudinal association with disease severity.Molecular genetics and metabolism
Establishment of an N-Glycan Profiling Method for Three ERT Enzymes Used in Gaucher Disease Therapy.Molecules (Basel, Switzerland)
ÁttekintésFrom Lysosomal Storage to Neurodegeneration: Sphingolipid Signaling as a Driver of CNS Pathology and Biomarker Strategy in Neuronopathic Gaucher Disease.International journal of molecular sciences
EsetismertetésDiagnosis and follow-up of the first case of Gaucher disease under enzyme replacement therapy in Senegal.Ghana medical journal
Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease-Associated Parkinsonism: Insights Into a Potential Therapeutic Target.Journal of cellular and molecular medicine
Multivalent C2-alkyl trihydroxypiperidine architectures modulate β-glucocerebrosidase activity.European journal of medicinal chemistry
Transcriptomic Profiling of Monozygotic Twins with Type 1 Gaucher Disease.Life (Basel, Switzerland)
EsetismertetésFetal/Perinatal Lethal Gaucher Disease: A Case Series.Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
[Efficacy and safety of eliglustat tartrate in adults with Gaucher disease type 1].Zhonghua yi xue za zhi
EsetismertetésGaucher disease: the hematologist's perspective of a multisystemic disorder.Annals of hematology
ÁttekintésPharmacotherapies for Gaucher disease: what's new on the horizon?Expert opinion on pharmacotherapy
ÁttekintésTargeting lysosomal dysfunction with small-molecule TRPML1 ligands: Therapeutic opportunities in lysosomal storage disorders, neurodegeneration and beyond.European journal of medicinal chemistry
Correction to "Evaluation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for Parkinsonism".Movement disorders : official journal of the Movement Disorder Society
Emerging pharmacotherapies in Gaucher disease.Expert opinion on emerging drugs
Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease.International journal of molecular sciences
Risk Is Not Destiny: Unmasked Penetrance of Parkinson Disease in Gaucher Disease.Neurology
MetaanalízisGenotype-phenotype correlations and mutation spectrum of GBA1 in Gaucher disease across Asian populations: a systematic review.Human genomics
Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry.Neurology
PreprintA Multiscale Signaling-Biophysical Framework Reveals Mechanisms of Macrophage-Mediated RBC Clearance in Sickle Cell and Gaucher Disease.bioRxiv : the preprint server for biology
The c-Abl-RIPK3 Axis Drives Mitochondrial Dysfunction and Impaired Mitophagy in Gaucher Disease Models.Antioxidants (Basel, Switzerland)
Family studies in Gaucher Disease: a key resource for early diagnosis and personalized treatment strategies.Orphanet journal of rare diseases
Left Ventricular Global Longitudinal Strain as an Early Predictor of Disease Severity Progression in Gaucher Disease Type 1.Echocardiography (Mount Kisco, N.Y.)
Megfigyeléses vizsgálatLongitudinal Evaluation of Neurological and Sensory Changes in Gaucher Disease: A Prospective Observational Cohort Study (SENOPRO).Medical sciences (Basel, Switzerland)
Adverse events signals of enzyme replacement drugs of Gaucher disease: insights from FAERS database analysis.Frontiers in medicine
Genomic Structural Equation Modeling Provides an Initial View of the Genetic Architecture Related to Type 1 Gaucher Disease.Human mutation
EsetismertetésAddressing kyphoscoliosis in Gaucher's disease: a multidisciplinary approach to a rare case.BMC musculoskeletal disorders
Irányelv[Expert consensus on neonatal screening for common lysosomal storage disorders(2026)].Zhonghua er ke za zhi = Chinese journal of pediatrics
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.Journal of clinical medicine
A bioinformatics-guided analytical approach for drug repositioning: Colchicine as a candidate for gaucher disease treatment.Analytical biochemistry
Childhood Interstitial Lung Disease in Metabolic Disorders: Prevalence, Genotypic and Clinical Characteristics, and Management Approaches: An Analysis of the Child-Turkey Registry.Pediatric pulmonology
EsetismertetésChronic Myeloid Leukemia Transforming into Acute Lymphoblastic Leukemia in a Patient with Gaucher Disease: A Case Report and Literature Review.Case reports in oncology
Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China.Journal of clinical medicine
Safety and Efficacy of Ambroxol Therapy in Polish Patients with Gaucher Disease.Life (Basel, Switzerland)
Development and optimization of human glucocerebrosidase-encoding mRNA for Gaucher disease therapy.Biochemical and biophysical research communications
Reference intervals for lysosomal glucocerebrosidase activity in the healthy population.Scandinavian journal of clinical and laboratory investigation
The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher Group Gaucher Registry.Orphanet journal of rare diseases
ÁttekintésRepurposing Gaucher disease therapy for Saposin C deficiency: Proof-of-concept with eliglustat.Molecular genetics and metabolism
Vizsgálati eredményIncreased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.Journal of internal medicine
ÁttekintésGlucosylsphingosine (Lyso-Gb1): An Update on Its Use as a Biomarker in Gaucher Disease.International journal of molecular sciences
Stability study of pharmacy compounded high-dose ambroxol hydrochloride capsules for an n-of-1 clinical trial involving Dutch patients with Gaucher disease type 3.European journal of hospital pharmacy : science and practice
Gaucher disease masked by childhood splenectomy: a forty-year diagnostic delay.Polish archives of internal medicine
TikTok as a Platform for Patient Education and Health Information in Rare Genetic Diseases: Cross-Sectional Study.JMIR formative research
Development of Nickel Prussian Blue Analogue Nanoparticles Stabilizing the Glucocerebrosidase in the Treatment of Gaucher Disease (GD).ACS applied materials & interfaces
Exploring delayed diagnosis in Gaucher disease: insights from a community survey and potential solutions.Orphanet journal of rare diseases
Megfigyeléses vizsgálatMaternal and Fetal Outcomes in Imiglucerase-Treated Patients With Gaucher Disease: Real-World Evidence From the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub-Registry.Journal of inherited metabolic disease
Excess Risk of Monoclonal Gammopathy in Patients With Gaucher Disease.American journal of hematology
EsetismertetésUnveiling an Uncommon Glucosylceramidase (GBA) Mutation: Gaucher Disease Due to p.Ser276Phe Substitution.Cureus
EsetismertetésCase Report: Progressive myoclonus epilepsy as an early manifestation of neuronopathic Gaucher disease.Frontiers in neuroscience
Exploring the long-term use of ambroxol in Gaucher disease type 2: insights from two pediatric cases.Frontiers in neurology
Improving access to rare disease diagnostics in Africa: insights from a multinational pilot study.Orphanet journal of rare diseases
Szisztematikus áttekintésInvestigating the therapeutic profile of velaglucerase alfa in paediatric patients with Gaucher disease: a systematic review across all paediatric age groups.Orphanet journal of rare diseases
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: The "Ichnos" Project.Mediterranean journal of hematology and infectious diseases
Development of national biobank for lysosomal storage disorders in India- a step towards advancing research and precision medicine.Orphanet journal of rare diseases
Quantitative and Comparative Assessment of Recombinant Human β-Glucocerebrosidase Uptake Bioactivity Using a Stable hMMR-Expressing CHO Cell Model.Molecules (Basel, Switzerland)
Constraint-based modelling of metabolic dysregulation in Gaucher disease: mitochondrial dysfunction and disrupted cholesterol homeostasis.Orphanet journal of rare diseases
HEPES in Cell Culture Alters the Multi-Omics Profile Exhibited by Gaucher Disease Fibroblasts.Journal of cellular biochemistry
EsetismertetésPhenotypic Spectrum of Type 2-3 Gaucher Disease: A Case Study in the Balkan Genotype.The American journal of case reports
ÁttekintésNatural-History Mapping of Lysosomal Storage Disorders (LSDs): Gaucher Disease as a Model for Precision Care.Journal of inherited metabolic disease
Concurrent Iliac Aneurysm in a Case of Gaucher's Disease: A Rare Occurrence.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Genetic Modeling of Lysosomal Storage Disorders (LSDs) in the Brain-Midgut Axis of Drosophila melanogaster During Aging.Cells
Assessment of liver and spleen stiffness and hepatic steatosis by transient elastography (Fibroscan®) in type 1 Gaucher disease: a single center case-control cohort study.Orphanet journal of rare diseases
Áttekintés[Disease severity assessment and standardized follow-up for Gaucher disease].Zhonghua nei ke za zhi
Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3.Annals of medicine and surgery (2012)
Prenatal Testing of a Complex Pathogenic Variant following Positive Carrier Screening for Gaucher Disease.Clinical chemistry
ÁttekintésRefining Mouse Models of Gaucher Disease: Advancing Mechanistic Insights, Biomarker Discovery, and Therapeutic Strategies.International journal of molecular sciences
Commentary on Prenatal Testing of a Complex Pathogenic Variant following Positive Carrier Screening for Gaucher Disease.Clinical chemistry
Commentary on Prenatal Testing of a Complex Pathogenic Variant following Positive Carrier Screening for Gaucher Disease.Clinical chemistry
ÁttekintésLysosomal storage diseases in North America: a comprehensive review of enzyme therapies and unmet needs.Therapeutic advances in rare disease
ÁttekintésThe Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism.Movement disorders : official journal of the Movement Disorder Society
EsetismertetésHomozygous GBA1 p.T82I variant in type 1 Gaucher disease: clinical and biochemical characterization.Personalized medicine
Neutral sp2-iminosugars exploiting non-glycone interactions for selective acid α- and β-glucosidase activity modulation: Pharmacological chaperones for Gaucher and Pompe diseases.European journal of medicinal chemistry
AAV gene therapy for GBA1-related diseases.Molecular therapy : the journal of the American Society of Gene Therapy
Microbiome-gut-heart axis in cardiac complications of Gaucher disease type 3.Annals of medicine and surgery (2012)
EsetismertetésRare in Rare: Overlapping Clinical Features in a Patient With Both Gaucher Disease Type 1 and B4GALT-CDG: Expanding the Clinical Spectrum With a Novel Pathogenic Variant.Clinical genetics
Transcriptomic signatures in Gaucher disease subtypes: A systems biology perspective.Molecular genetics and metabolism reports
ÁttekintésSecondary Mitochondrial Dysfunction in Gaucher Disease Type I, II and III-Review of the Experimental and Clinical Evidence.Genes
Gaucher Disease-Correlation of Lyso-Gb1 with Haematology and Biochemical Parameters.Metabolites
Metabolic reprogramming and altered ATP content impair neuroprotective functions of microglia in β-glucocerebrosidase deficiency models.Journal of neuroinflammation
PreprintPatient-Specific Midbrain Organoids with CRISPR Correction Reveal Disease Mechanisms and Enable Therapeutic Evaluation in Neuronopathic Gaucher Disease.bioRxiv : the preprint server for biology
Precision genomic profiling in Gaucher disease: insights from atypical presentations.Frontiers in genetics
Megfigyeléses vizsgálatMarkers of Inflammation and Autoinflammation in Patients With Gaucher Disease: A Single-Center Observational Study.Clinical pediatrics
Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.Orphanet journal of rare diseases
MetaanalízisGBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility.Movement disorders : official journal of the Movement Disorder Society
Liver involvement in Gaucher disease type I: a retrospective single-center study from Ukraine.Frontiers in medicine
EsetismertetésPerinatal-Onset Neuronopathic Gaucher Disease Is Refractory to High-Dose Ambroxol: A Case Report and Literature Review.Neonatology
Bone involvement in Gaucher disease: Data from a North African registry.Reumatologia clinica
Inhibition or genetic reduction of ASAH1/acid ceramidase restore α-synuclein clearance in mutant GBA1 dopamine neurons from Parkinson's patients.Human molecular genetics
The Gaucher Earlier Diagnosis Consensus point-scoring system for children and young adults: a retrospective and prospective evaluation in Korea.Orphanet journal of rare diseases
MyGauchTM: a patient-centered digital health app for Gaucher disease.mHealth
Correlation of Plasma Lyso-GL1 Levels with Clinical Phenotype and Treatment Decisions in Patients with Gaucher Disease.Molecular genetics and metabolism
Szisztematikus áttekintésSphingolipids in Gaucher disease: a systematic review.Orphanet journal of rare diseases
Enzyme replacement therapy in infants and very young children with Gaucher disease using velaglucerase alfa: a single-center experience.Frontiers in pediatrics
Cytotoxic lymphocyte effector function is unaffected in patients with Gaucher disease.Frontiers in immunology
An injectable hydrogel containing N-acetylglycine for the treatment of Gaucher disease.RSC advances
Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes.Orphanet journal of rare diseases
Clinical Variability and Genotype-Phenotype Correlation in Spanish Patients with Type 1 Gaucher Disease: A Focus on Non-c.[1226A>G]; [1448T>C] Genotypes.International journal of molecular sciences
Selenoureido-N-alkyl-3,4,5-trihydroxypiperidines: probing their dual-target role in Gaucher disease.Bioorganic & medicinal chemistry
ÁttekintésFrench national diagnosis and care protocol (Protocole National De Diagnostic et de Soins; PNDS): Gaucher disease.Orphanet journal of rare diseases
ÁttekintésPulmonary Manifestations of Lysosomal Storage Disorders in Adults.Clinics in chest medicine
EsetismertetésGaucher syndrome: report of six cases and review of genetic mutations among Iranian patients.Neurogenetics
Ten-Year Follow-Up of Taliglucerase Alfa in Type 1 Gaucher Disease: Real-World Evidence from Albania.Journal of clinical medicine
Real-world experience of switching to taliglucerase among patients with Gaucher disease in Québec: A case series.Molecular genetics and metabolism reports